High-Tech Microscope Constructed for Low Cost
|
By LabMedica International staff writers Posted on 08 Dec 2014 |

Image: The low cost microscope system constructed to perform multiple simultaneous time-lapse studies on various cell types (Photo courtesy of Adam Lynch).
The direct visualization of cells for the purpose of studying their motility has typically required expensive microscopy equipment; however, recent advances in digital sensors mean that it is now possible to image cells for a fraction of the price of a standard microscope.
The development and performance of an expandable cell motility system has been described that employs inexpensive, commercially available digital Universal Serial Bus (USB) microscopes to image various cell types using time-lapse and perform tracking assays.
Scientists at Brunel University (Uxbridge, UK) constructed the apparatus from cheaply bought materials. Various lighting sources were tested, and ultimately a light-emitting diode (LED) strip desk lamp was selected. An incubation chamber was developed to fit over the top of the stage and the chamber was made from transparent acrylic to allow visualization inside.
The three microscopes used were identical models (VMS-004D, Veho; Southampton, UK) in order to prevent any discrepancies. These microscopes use a complementary metal–oxide–semiconductor (CMOS) image sensor with 1.3 mega-pixel resolution. Magnification has two set levels, from approximately ×20 minimum to around ×400 maximum, achieved using a focusing wheel. To enhance stability, magnification and to allow for observation of live samples in liquid (cells) the microscopes were inverted.
The imaging capability of the system was compared to a conventional inverted microscope fitted with a 1.3 megapixel camera. The highest magnification on the conventional microscope was greater than the constructed system, but the maximum pixel resolution of images was the same. Spatial resolution on the conventional microscope was higher and intra-cellular detail could be seen at the highest magnification that could not be distinguished in the innovative system when images were enlarged to match the size.
The authors concluded that the novel cell tracking system had the ability to perform multiple simultaneous time-lapse studies on various cell types. Due to its low-cost, portability and commercially available components they believe that this system has the potential to enable time-lapse studies by non-specialist departments, and may be a practical solution for scientists with limited financial resources. The study was published on August 14, 2014, in the journal Public Library of Science ONE.
Related Links:
Brunel University
Veho
The development and performance of an expandable cell motility system has been described that employs inexpensive, commercially available digital Universal Serial Bus (USB) microscopes to image various cell types using time-lapse and perform tracking assays.
Scientists at Brunel University (Uxbridge, UK) constructed the apparatus from cheaply bought materials. Various lighting sources were tested, and ultimately a light-emitting diode (LED) strip desk lamp was selected. An incubation chamber was developed to fit over the top of the stage and the chamber was made from transparent acrylic to allow visualization inside.
The three microscopes used were identical models (VMS-004D, Veho; Southampton, UK) in order to prevent any discrepancies. These microscopes use a complementary metal–oxide–semiconductor (CMOS) image sensor with 1.3 mega-pixel resolution. Magnification has two set levels, from approximately ×20 minimum to around ×400 maximum, achieved using a focusing wheel. To enhance stability, magnification and to allow for observation of live samples in liquid (cells) the microscopes were inverted.
The imaging capability of the system was compared to a conventional inverted microscope fitted with a 1.3 megapixel camera. The highest magnification on the conventional microscope was greater than the constructed system, but the maximum pixel resolution of images was the same. Spatial resolution on the conventional microscope was higher and intra-cellular detail could be seen at the highest magnification that could not be distinguished in the innovative system when images were enlarged to match the size.
The authors concluded that the novel cell tracking system had the ability to perform multiple simultaneous time-lapse studies on various cell types. Due to its low-cost, portability and commercially available components they believe that this system has the potential to enable time-lapse studies by non-specialist departments, and may be a practical solution for scientists with limited financial resources. The study was published on August 14, 2014, in the journal Public Library of Science ONE.
Related Links:
Brunel University
Veho
Latest Technology News
- ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
- Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
- New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
- Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
- Autonomous Robotic System Receives FDA Authorization for Blood Collection
- Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
- Training Device Improves Accuracy of Pooled Molecular Diagnostics
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
Channels
Clinical Chemistry
view channel
Blood Test Patterns Improve Cancer Risk Assessment in Primary Care
Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more
Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection
Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more
Machine Learning Supports Targeted Screening for Elevated Lipoprotein(a)
Lipoprotein(a) is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease, yet routine screening remains uncommon despite guideline recommendations, leaving many high-risk... Read more
Blood Biomarker May Help Monitor Early Response to Lecanemab in Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerative disorder marked by amyloid-beta and tau pathology and remains a leading cause of cognitive decline in older adults. Although lecanemab, an anti-amyloid... Read moreMolecular Diagnostics
view channel
Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples
Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more
FDA Clears Compact Molecular COVID Test for Decentralized Care Settings
Decentralized healthcare settings such as urgent care clinics have historically struggled to deploy high-performance molecular testing. Barriers include high upfront costs, fixed testing capacity, large... Read moreHematology
view channel
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read more
New Automated Hemostasis Systems Become Available Across US Laboratories
Hemostasis testing supports critical decisions in surgery, anticoagulation management, and the evaluation of bleeding and thrombotic disorders, but laboratories continue to face rising volumes and complex... Read moreImmunology
view channel
Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead
Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more
New Cellular Map May Help Predict Crohn’s Disease Course in Children
Crohn’s disease in children is a common and debilitating form of inflammatory bowel disease, marked by chronic intestinal inflammation and limited pediatric-specific treatments. Clinicians must decide... Read more
Temporal Immune Profiling Reveals How Sepsis States Change Over Time
Sepsis is a life-threatening condition in which the immune response to infection becomes dysregulated, leading to rapid organ failure and death. Although antimicrobials and organ support remain standard... Read more
Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19
Autoantibodies that mistakenly attack the body’s own tissues have been linked to severe COVID-19, Long COVID, and increased risk of autoimmune disease. However, the origins of these autoantibodies during... Read moreMicrobiology
view channelMagnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing
Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more
Infant Skin Microbiome Show Links to Later Eczema and Food Allergies
Eczema, or atopic dermatitis, and food allergies often begin in infancy and are among the earliest stages of the atopic march. Atopic dermatitis alone can affect up to 20% of children, yet objective indicators... Read more
Diagnostic Stewardship Guide Targets Testing Overuse and Hospital Cost Pressures
Hospitals face persistent pressure to improve diagnostic accuracy while reducing unnecessary testing and costs. Misordered or overused assays can complicate infection metrics, trigger penalties, and strain... Read more
Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics
Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read morePathology
view channel
Machine Learning Cytology Tool Improves Cancer Cell Identification
Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more
Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer
Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more
CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing
Standardized biomarker reporting and molecular profiling are central to pathology-driven cancer care, but evolving practices require laboratories to keep reporting templates current. These templates capture... Read moreIndustry
view channel
Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities
Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Unilabs Expands Digital Pathology Across European Network with Proscia Platform
As precision medicine expands, digital pathology platforms must connect teams, sites, diagnostic data, and artificial intelligence to accelerate routine diagnosis. Sharing expertise across laboratory networks... Read more
MGI Launches Automated Multiplex Tissue Staining and Imaging System at ECP 2026
MGI Tech Co., Ltd. (Shenzhen, China) introduced VisiOmics (PMIF-20RS), a fully automated multiplex immunofluorescence staining and imaging system, at the 38th European Congress of Pathology (ECP 2026)... Read more







